Axonics reports fourth quarter and fiscal year 2022 financial results

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months and fiscal year ended december 31, 2022. “this quarter's record results reflect the growing demand for our best-in-class incontinence products,” said raymond w. cohen, chief executive officer of axonics. “our u.s.
AXNX Ratings Summary
AXNX Quant Ranking